1. Home
  2. SPTN vs IVA Comparison

SPTN vs IVA Comparison

Compare SPTN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPTN
  • IVA
  • Stock Information
  • Founded
  • SPTN 1917
  • IVA 2011
  • Country
  • SPTN United States
  • IVA France
  • Employees
  • SPTN N/A
  • IVA N/A
  • Industry
  • SPTN Food Distributors
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPTN Consumer Discretionary
  • IVA Health Care
  • Exchange
  • SPTN Nasdaq
  • IVA Nasdaq
  • Market Cap
  • SPTN 900.1M
  • IVA 769.0M
  • IPO Year
  • SPTN N/A
  • IVA 2020
  • Fundamental
  • Price
  • SPTN $26.48
  • IVA $5.30
  • Analyst Decision
  • SPTN Hold
  • IVA Strong Buy
  • Analyst Count
  • SPTN 1
  • IVA 6
  • Target Price
  • SPTN $26.90
  • IVA $15.33
  • AVG Volume (30 Days)
  • SPTN 725.8K
  • IVA 74.0K
  • Earning Date
  • SPTN 11-06-2025
  • IVA 09-26-2025
  • Dividend Yield
  • SPTN 3.32%
  • IVA N/A
  • EPS Growth
  • SPTN N/A
  • IVA N/A
  • EPS
  • SPTN N/A
  • IVA N/A
  • Revenue
  • SPTN $9,693,074,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • SPTN $6.07
  • IVA $80.35
  • Revenue Next Year
  • SPTN N/A
  • IVA N/A
  • P/E Ratio
  • SPTN N/A
  • IVA N/A
  • Revenue Growth
  • SPTN 1.54
  • IVA N/A
  • 52 Week Low
  • SPTN $17.30
  • IVA $1.53
  • 52 Week High
  • SPTN $26.89
  • IVA $6.50
  • Technical
  • Relative Strength Index (RSI)
  • SPTN 47.47
  • IVA 54.11
  • Support Level
  • SPTN $26.14
  • IVA $5.21
  • Resistance Level
  • SPTN $26.58
  • IVA $5.78
  • Average True Range (ATR)
  • SPTN 0.11
  • IVA 0.33
  • MACD
  • SPTN -0.08
  • IVA -0.37
  • Stochastic Oscillator
  • SPTN 45.33
  • IVA 81.61

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: